Non-canonical and induced neoantigens as emerging sources of cancer-specific immunotherapy targets - Quiz - MDSpire

Non-canonical and induced neoantigens as emerging sources of cancer-specific immunotherapy targets

  • By

  • Viacheslav V. Kudriavskii

  • Valeriia A. Koss

  • Victoria O. Shender

  • Georgij P. Arapidi

  • July 2, 2026

  • 0 min

Share

Original Source(s)

Non-canonical and induced neoantigens as emerging sources of cancer-specific immunotherapy targets

  • by Viacheslav V. Kudriavskii, Valeriia A. Koss, Victoria O. Shender, Georgij P. Arapidi

  • July 2, 2026

Related Content

Correction: Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells

Optimizing immunotherapy in advanced gastric cancer: established and emerging biomarkers for precision patient selection

Editorial: National Colorectal Cancer Awareness Month 2025: Current Progress and Future Prospects on Colorectal Cancer Prevention, Diagnosis and Treatment